CT scan Findings of COVID-19 in Patients with Fatty Liver
Keywords:CT scan, COVID 19, Fatty Liver.
Purpose: COVID 19) is a respiratory disease caused by a member of the coronaviruses family, named
(SARS-CoV-2), discovered in December 2019 in China. This study aims to assess the association of the
simple fatty liver disease with the severity of the chest computed tomography (CT) scan findings in COVID
Materials and Methods: It was a cross-sectional study that enrolled 322 patients with positive (RT-PCR)
tests and chest CT scan findings. Patients with chronic lung and liver disease, alcoholics, and abnormal liver
function tests excluded from the study. The liver CT scan density assessed, accordingly the patients divided
into fatty-liver and non-fatty liver groups. The severity of lung CT changes compared between them, using
Conclusion: COVID patients with fatty liver have more progressive changes in the chest CT scan. They
have similar lung lesion distribution to non- fatty liver patients. Crazy paving lesions, septal thickening,
Lymphadenopathy and plural effusion in fatty liver patients occurs in the same frequency as non-fatty liver
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Re use and mixing of content policy- We follow Creative Commons Licence Policy. We follow CC BY. Please refer below for all details
This license lets others distribute, remix, adapt, and build upon our work, even commercially, as long as they credit us for the original creation.
- The journal allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose.
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to retain publishing rights without restrictions